HERPES VIRUS (HHV 2) - ANVISA Registration 10259610190

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610190 and manufactured by QUIDEL CORPORATION. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Jan 08, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASORIN ITALIA S.P.A., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610190
2 Related Devices
Registration Details
ANVISA Registration Number: 10259610190
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

AmpliVue HSV 1+2
Risk Class III

Registration Details

10259610190

25351594612201758

68814961000173

Company Information

QUIDEL CORPORATION
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jan 08, 2018

08/01/2028

09/18/2025 19:00:01

AmpliVue HSV 1+2
Risk Class III

Registration Details

10259610190

25351594612201758

68814961000173

Company Information

Dates and Status

Jan 08, 2018

08/01/2028

09/18/2025 19:00:01